Article Information
History
- February 10, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Pieter T. de Boer1,†,
- Jan van de Kassteele1,*,
- Eric R.A. Vos1,*,
- Liselotte van Asten1,
- Dave A. Dongelmans2,3,
- Arianne B. van Gageldonk-Lafeber1,
- Gerco den Hartog1,4,
- Agnetha Hofhuis1,
- Fiona van der Klis1,
- Dylan W. de Lange5,
- Lenny Stoeldraijer6,
- the RIVM COVID-19 epidemiology and surveillance team1,
- Hester E. de Melker1,
- Eveline Geubbels1,
- Susan van den Hof1,* and
- Jacco Wallinga1,7,*
- 1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), the Netherlands
- 2Department of Intensive Care Medicine, Amsterdam UMC (location AMC), Amsterdam, the Netherlands
- 3Amsterdam Public Health Research Institute, Amsterdam, the Netherlands
- 4Laboratory of Medical Immunology, Radboudumc, Nijmegen, the Netherlands
- 5Intensive Care, University Medical Center Utrecht, University Utrecht, the Netherlands
- 6Statistics Netherlands, the Netherlands
- 7Department of Biomedical Datasciences, Leiden University Medical Center, the Netherlands
- ↵†Correspondence:
Pieter de Boer (pieter.de.boer{at}rivm.nl)
↵* These authors contributed equally to the manuscript